approved EB-1A
Research Associate
Microbiology · India · 2022-03-26
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.
Framework Evaluation
3 of 3 criteria metScholarly Articles (Met)
The petitioner authored 40 peer-reviewed articles and 6 book chapters in international journals, with 1,010 citations placing him in the top 1% of cited authors in his field.
Judging (Met)
The petitioner completed at least 70 peer review invitations for journals in the field.
Original Contributions (Met)
Developed a novel antiviral approach and molecular gene-silencing strategy for influenza treatment, supported by funding from the U.S. CDC.
Why This Petition Was Approved
The petition was approved based on 40 peer-reviewed articles, 6 book chapters, and a significant citation count of 1,010. The petitioner also demonstrated professional standing through 70 peer review assignments. The work was recognized by researchers in over 50 countries and supported by funding from the U.S. CDC.
Evidence
Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Grants
Judging Experience
Original Contributions
Evidence Submitted
- 40 peer-reviewed articles
- 6 book chapters
- 1,010 citations from peers in 50 countries
- 70 peer review assignments
- Funding from U.S. Centers for Disease Control and Prevention (CDC)
- Epidemiological investigation on 2009 H1N1 pandemic strains
Similar Cases
Research Scientist
Biotechnology · India
WeGreened EB-1A approved
Massachusetts 17 days 2025-01-24
The petition was approved based on a strong record of 44 peer-reviewed journal articles and 4,450 citations, demonstrating significant influence in the field. The petitioner also provided evidence of 26 peer reviews for scientific journals and international media coverage of his findings. These metrics satisfied the EB-1A criteria for scholarly articles, original contributions, and judging the work of others.
Assistant Professor
Research and Development · India
WeGreened EB-1A approved
Michigan 18 days 2025-06-14
The petition was approved based on 14 peer-reviewed journal articles, 1 preprint, and 1 book chapter published in high-ranking journals. The petitioner demonstrated 219 citations and over 40 instances of peer review service for top scientific journals and funding agencies. Additionally, ongoing research support from prominent international funding bodies evidenced sustained recognition in the field.
Others
Biotechnology · Bangladesh
WeGreened EB-1A rfe approved
New York 100 days 2026-01-13
Approval was based on a robust record of 74 peer-reviewed journal articles and 4 preprints with 1,777 citations, demonstrating field-wide influence. The petitioner also completed at least 40 peer reviews, signifying recognized authority. Additionally, the work attracted support from major U.S. research sponsors and state-level departments.
Research Scientist
Biotechnology · China
WeGreened EB-1A rfe approved
California 105 days 2025-10-16
The petitioner submitted 17 peer-reviewed articles and 1 book chapter with a high citation count of 775 from 34 countries. The case demonstrated extraordinary ability through scholarly articles, original contributions to the field of Alzheimer's and COVID-19, and a significant record of 22 peer reviews.
Frequently Asked Questions
A approved EB-1A (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.
Browse More Cases
Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-03-26.
Browse all casesAt a Glance
Outcome approved
Processing 128 days
Criteria Met 3 / 3
Evidence Types 6
EB-1A Case Data
Scraped Case Data
Total Cases 881
Success Rate 52.9%
Sustained 466
Dismissed 299
Related Pages
Get Case Insights
Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.
Join Waitlist